Live feed08:18:52·247dPRReleasevia QuantisnowScience 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease TrialByQuantisnow·Wall Street's wire, on your screen.SNCE· Science 37 Holdings Inc.Technology
